These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 24763772)
1. Blonanserin improved dystonia induced by risperidone or olanzapine in two patients with schizophrenia. Takaki M; Mizuki Y; Miki T J Neuropsychiatry Clin Neurosci; 2014 Apr; 26(2):E14. PubMed ID: 24763772 [No Abstract] [Full Text] [Related]
2. Blonanserin ameliorated the tendency toward QTc prolongation associated with risperidone in a patient with schizophrenia. Mizuki Y; Takaki M J Clin Psychopharmacol; 2015 Feb; 35(1):101-2. PubMed ID: 25502488 [No Abstract] [Full Text] [Related]
3. Efficacy and tolerability of Blonanserin in the patients with schizophrenia: a randomized, double-blind, risperidone-compared trial. Yang J; Bahk WM; Cho HS; Jeon YW; Jon DI; Jung HY; Kim CH; Kim HC; Kim YK; Kim YH; Kwon JS; Lee SY; Lee SH; Yi JS; Yoon BH; Kim SH Clin Neuropharmacol; 2010 Jul; 33(4):169-75. PubMed ID: 20661022 [TBL] [Abstract][Full Text] [Related]
4. Ziprasidone versus olanzapine, risperidone or quetiapine in patients with chronic schizophrenia: a 12-week open-label, multicentre clinical trial. Lublin H; Haug HJ; Koponen H; Sigmundsson T; Kolb SA World J Biol Psychiatry; 2009; 10(4 Pt 3):710-8. PubMed ID: 18803070 [TBL] [Abstract][Full Text] [Related]
5. Effects of aripiprazole on prolactin levels in subjects with schizophrenia during cross-titration with risperidone or olanzapine: analysis of a randomized, open-label study. Byerly MJ; Marcus RN; Tran QV; Eudicone JM; Whitehead R; Baker RA Schizophr Res; 2009 Feb; 107(2-3):218-22. PubMed ID: 19038534 [TBL] [Abstract][Full Text] [Related]
6. [Blonanserin in the treatment of schizophrenia]. Tenjin T; Miyamoto S Nihon Rinsho; 2013 Apr; 71(4):660-5. PubMed ID: 23678596 [TBL] [Abstract][Full Text] [Related]
7. One-year follow-up study of psychotic patients treated with blonanserin: a case series. Takahashi S; Suzuki M; Uchiyama M Asia Pac Psychiatry; 2013 Sep; 5(3):164-7. PubMed ID: 23857800 [TBL] [Abstract][Full Text] [Related]
8. Unexpected dystonia while changing from clozapine to risperidone. Radford JM; Brown TM; Borison RL J Clin Psychopharmacol; 1995 Jun; 15(3):225-6. PubMed ID: 7543499 [No Abstract] [Full Text] [Related]
9. Reappearance of tardive dystonia with olanzapine treated with clozapine. García-Lado I; García-Caballero A; Recimil MJ; Area R; Ozaita G; Lamas S Schizophr Res; 2005 Jul; 76(2-3):357-8. PubMed ID: 15949669 [No Abstract] [Full Text] [Related]
10. Management of a risperidone-induced tardive Pisa syndrome: a case report. Kaufmann A; Boesch S; Fleischhacker WW; Hofer A J Clin Psychopharmacol; 2012 Jun; 32(3):418-20. PubMed ID: 22561474 [No Abstract] [Full Text] [Related]
11. Predictors of antipsychotic-induced weight gain in first-episode psychosis: conclusions from a randomized, double-blind, controlled prospective study of olanzapine, risperidone, and haloperidol. Saddichha S; Ameen S; Akhtar S J Clin Psychopharmacol; 2008 Feb; 28(1):27-31. PubMed ID: 18204337 [TBL] [Abstract][Full Text] [Related]
12. Obsessive-compulsive symptoms in patients with schizophrenia: a naturalistic cross-sectional study comparing treatment with clozapine, olanzapine, risperidone, and no antipsychotics in 543 patients. Scheltema Beduin AA; Swets M; Machielsen M; Korver N; J Clin Psychiatry; 2012 Nov; 73(11):1395-402. PubMed ID: 23218156 [TBL] [Abstract][Full Text] [Related]
13. Cochrane for clinicians. Aripiprazole vs. other atypical antipsychotics for schizophrenia. Guirguis-Blake J Am Fam Physician; 2010 Jun; 81(11):1335-6. PubMed ID: 20521753 [No Abstract] [Full Text] [Related]
14. Olanzapine-induced oculogyric crisis in a patient with schizophrenia. Chakraborty R; Chatterjee A; Chaudhury S Indian J Med Sci; 2008 Jun; 62(6):238-9. PubMed ID: 18603742 [No Abstract] [Full Text] [Related]
15. Model-based analysis of therapeutic efficacy of blonanserin and risperidone in schizophrenia patients and effects on prolactin: A randomized double-blind study. Yu W; Lei L; Yu Y; Li Y; Shen Y; Li H Hum Psychopharmacol; 2020 Jan; 35(1):e2717. PubMed ID: 31837240 [TBL] [Abstract][Full Text] [Related]
17. A randomised controlled study of risperidone and olanzapine for schizophrenic patients with neuroleptic-induced acute dystonia or parkinsonism. Chan HY; Chang CJ; Chiang SC; Chen JJ; Chen CH; Sun HJ; Hwu HG; Lai MS J Psychopharmacol; 2010 Jan; 24(1):91-8. PubMed ID: 18801830 [TBL] [Abstract][Full Text] [Related]
18. Cardiovascular variability during treatment with haloperidol, olanzapine or risperidone in recent-onset schizophrenia. Hempel RJ; Tulen JH; van Beveren NJ; Röder CH; Hengeveld MW J Psychopharmacol; 2009 Aug; 23(6):697-707. PubMed ID: 18562420 [TBL] [Abstract][Full Text] [Related]
19. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. Lieberman JA; Stroup TS; McEvoy JP; Swartz MS; Rosenheck RA; Perkins DO; Keefe RS; Davis SM; Davis CE; Lebowitz BD; Severe J; Hsiao JK; N Engl J Med; 2005 Sep; 353(12):1209-23. PubMed ID: 16172203 [TBL] [Abstract][Full Text] [Related]
20. Switching antipsychotics to aripiprazole or blonanserin and plasma monoamine metabolites levels in patients with schizophrenia. Miura I; Shiga T; Katsumi A; Kanno-Nozaki K; Mashiko H; Niwa S; Yabe H Hum Psychopharmacol; 2014 Mar; 29(2):199-202. PubMed ID: 24590545 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]